Clinical Trial Results:
Oral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism.
Summary
|
|
EudraCT number |
2006-004495-13 |
Trial protocol |
BE ES SE FR DE FI DK HU AT IT GB CZ NL IE LT EE LV SK |
Global completion date |
01 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Dec 2016
|
First version publication date |
13 Dec 2014
|
Other versions |
|
Summary report(s) |
Bayer Study Synopsis Bayer Study Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.